C/EBPβ activity is negatively regulated by AMP-activated protein kinase (AMPK), where activated AMPK suppresses C/EBPβ expression and inhibits PEPCK transcription in diabetes (46). The gene discussed is PRKAA2; the disease is diabetes mellitus.